Literature DB >> 8844247

Metoclopramide in a patient with renal failure may be an increased risk of neuroleptic malignant syndrome.

Y Fujita, T Yasukawa, M Mihira, T Sasaki, S Yokoya.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8844247     DOI： 10.1007/bf01709759

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Current concepts. Neuroleptic malignant syndrome.

Authors:  B H Guzé; L R Baxter
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

2.  Metoclopramide kinetics in patients with impaired renal function and clearance by hemodialysis.

Authors:  C R Lehmann; J D Heironimus; C B Collins; T J O'Neil; W P Pierson; J T Crowe; A P Melikian; G J Wright
Journal:  Clin Pharmacol Ther       Date:  1985-03       Impact factor: 6.875

3.  Metoclopramide-induced neuroleptic malignant syndrome.

Authors:  L S Friedman; L A Weinrauch; J A D'Elia
Journal:  Arch Intern Med       Date:  1987-08

4.  [Malignant neuroleptic syndrome under metoclopramide and neuroleptics in anuria].

Authors:  S Krähenbühl; J Raisin; T Herren
Journal:  Schweiz Med Wochenschr       Date:  1993-07-03

5.  Neuroleptic malignant-like syndrome induced by metoclopramide.

Authors:  M R Samie
Journal:  Mov Disord       Date:  1987       Impact factor: 10.338
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.